FDA Scrutinizes Side Effects of Diabetes, Weight-Loss Drugs

Published on January 4, 2024

The Food and Drug Administration has identified potential safety issues regarding diabetes and weight-loss medications such as Ozempic and Mounjaro, including hair loss, aspiration, and suicide ideation.

Read Full Article (External Site)